The first oral pill for obstructive sleep apnea could be around the corner after company Apnimed reported positive results ...

Once dismissed as just snoring, sleep apnea is now emerging as an early warning sign for serious conditions like Alzheimer’s, ...

In today’s Health Alert, obstructive sleep apnea may soon be treated with a simple, once-a-day pill. This first-in-class oral ...

* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...

Apnimed's experimental drug reduced breathing interruptions by nearly 46.8% in clinical trials, offering a potential ...

Obesity can lead to many complications, including increased risk for diabetes, heart disease, rheumatoid arthritis, depression, and high blood pressure. It can also lead to obstructive sleep apnea. 1 ...

All participants had obesity (BMI of ≥30 or ≥27 in Japan) and a diagnosis of moderate-to-severe obstructive sleep apnea (AHI ≥15 events per hour).

Obstructive sleep apnea is more common in men than women. Up to 34% of U.S. men have OSA compared to 17% of U.S. women, according to the American Academy of Family Physicians.

Source Reference: Pennings P, et al "Sleep-disordered breathing, sleep apnea, and other obesity-related sleep disorders: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

Tirzepatide (Zepbound and Mounjaro), which is approved for chronic weight management and treatment of type 2 diabetes, has significant benefits for patients with moderate-to-severe obstructive sleep ...

While obesity in of itself is not necessarily unhealthy, it can raise the risk of or worsen many chronic conditions, particularly obstructive sleep apnea.